» Articles » PMID: 39736736

PharmRL: Pharmacophore Elucidation with Deep Geometric Reinforcement Learning

Overview
Journal BMC Biol
Publisher Biomed Central
Specialty Biology
Date 2024 Dec 30
PMID 39736736
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Molecular interactions between proteins and their ligands are important for drug design. A pharmacophore consists of favorable molecular interactions in a protein binding site and can be utilized for virtual screening. Pharmacophores are easiest to identify from co-crystal structures of a bound protein-ligand complex. However, designing a pharmacophore in the absence of a ligand is a much harder task.

Results: In this work, we develop a deep learning method that can identify pharmacophores in the absence of a ligand. Specifically, we train a CNN model to identify potential favorable interactions in the binding site, and develop a deep geometric Q-learning algorithm that attempts to select an optimal subset of these interaction points to form a pharmacophore. With this algorithm, we show better prospective virtual screening performance, in terms of F1 scores, on the DUD-E dataset than random selection of ligand-identified features from co-crystal structures. We also conduct experiments on the LIT-PCBA dataset and show that it provides efficient solutions for identifying active molecules. Finally, we test our method by screening the COVID moonshot dataset and show that it would be effective in identifying prospective lead molecules even in the absence of fragment screening experiments.

Conclusions: PharmRL addresses the need for automated methods in pharmacophore design, particularly in cases where a cognate ligand is unavailable. Experimental results demonstrate that PharmRL generates functional pharmacophores. Additionally, we provide a Google Colab notebook to facilitate the use of this method.

Citing Articles

New strategies to enhance the efficiency and precision of drug discovery.

An Q, Huang L, Wang C, Wang D, Tu Y Front Pharmacol. 2025; 16:1550158.

PMID: 40008135 PMC: 11850385. DOI: 10.3389/fphar.2025.1550158.

References
1.
Koes D . The Pharmit Backend: A Computer Systems Approach to Enabling Interactive Online Drug Discovery. IBM J Res Dev. 2021; 62(6):1-6. PMC: 8049614. DOI: 10.1147/jrd.2018.2883977. View

2.
Zhu H, Zhou R, Cao D, Tang J, Li M . A pharmacophore-guided deep learning approach for bioactive molecular generation. Nat Commun. 2023; 14(1):6234. PMC: 10558534. DOI: 10.1038/s41467-023-41454-9. View

3.
Sato T, Honma T, Yokoyama S . Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening. J Chem Inf Model. 2009; 50(1):170-85. DOI: 10.1021/ci900382e. View

4.
Manepalli S, Geffert L, Surratt C, Madura J . Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore. J Chem Inf Model. 2011; 51(9):2417-26. PMC: 3183329. DOI: 10.1021/ci200280m. View

5.
Mysinger M, Carchia M, Irwin J, Shoichet B . Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012; 55(14):6582-94. PMC: 3405771. DOI: 10.1021/jm300687e. View